Societat
Actes
Characterization of the metabolic profile and identification of potential therapeutic targets in advanced prostate cancer patients
Auditórium
11:30
Identificación de GRHL2 como biomarcador epigenético en la resistencia a terapias anti-EGFR en el cáncer de pulmón no microcítico
Auditórium
11:00 horas
LH administration as a potential strategy for ovarian protection and female preservation against highly gonadotoxic chemotherapy
Auditórium
10:00 horas.
Identificación de nuevos biomarcadores de trombosis venosa mediante técnicas ómicas
Auditórium
11:30
Characterization of the epigenetic modifications in human uterine leiomyomas and evaluation of their potential as therapeutic targets in vitro
Auditórium
12:00 h.
Metabolomic approach to physiological circumstances and pathological conditions in neonatology
Auditórium
10:00 horas.
| dl. | dt. | dc. | dj. | dv. | ds. | dg. |
|---|---|---|---|---|---|---|
| 28 | 29 | 30 | 31 | 1 | 2 | 3 |
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 1 |
